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Background
Today’s biopharmaceutical industry is under increasing
pressure considering cost efficient development. Short
timeframes rule the progress starting from the genera-
tion of producer cell lines to the establishment of a final
production process. Hence, the timescale for optimiza-
tion of cell culture media is small, but on the other
hand it contains high potential for global process
improvement. In this scope, our specially tailored media
development platform, which allows a fast and reliable
introduction of high-performance basis media and feeds,
establishes new perspectives for an efficient process
development.
Materials and methods
For the design and development of TeutoCell’s new
media platform various cell lines and expression systems
were comprehensively analyzed and incorporated. The
results gained from cultivations and extensive analysis of
culture supernatant and e.g. product glycosylation were
integrated in a cyclic development strategy, utilizing the-
oretical and empirical formulation optimizations. Special
applications like single clone selection were integrated
into our platform as well.
The cell lines used for the development of our media
platform include CHO-DG44, CHO-GS and CHO-K1
clones. Cultivations were carried out in shaking flasks as
well as closed-loop controlled 0.5 - 2.0 L bioreactor sys-
tems in batch und fed-batch mode using standard condi-
tions. An industrially relevant, protein-free and chemically
defined medium was used as a reference.
Media development for single clone selection by limited
dilution was performed with different CHO suspension
cells in microtiter plates (from 96- to 6-wells) up to
shaking flaks. Analysis of single clone colonies was done
with a Cellscreen System.
Samples of a model antibody produced in commer-
cially available CHO reference medium and TeutoCell’s
platform medium using two different producer clones
were desalted, denaturated and treated with PNGaseF.
Glycans were concentrated via solid-phase extraction
and analyzed by MALDI-TOF mass spectrometry.
Signal-to-noise ratios of specific masses were used for
calculations of relative amounts.
Results
The performance of the platform medium was evaluated
using a set of eleven different CHO cell lines in compari-
son to an industrially relevant, protein-free and chemically
defined medium. For all tested cell lines, the maximum
viable cell density (vcd) as well as the integrated viable cell
density (ivcd) and the product titer were higher compared
to the reference. In numbers, the improvement in vcd ran-
ged between a factor of 1.7 and 2.5, in ivcd between a fac-
tor of 1.2 and 4.2 and in product titer between a factor of
1.4 and 2.7 in batch cultures. By this improvement viable
cell densities of up to 17.53·106 cells/mL and product titer
of 1015 mg/L were reached. An overview of these results
is illustrated in Figure 1.
Furthermore, the potential influence of the utilized med-
ium on product glycosylation was examined. For this, anti-
body harvest from two different clones cultivated in
reference and platform medium was analyzed. The results
of relative quantification of glycan structures by mass
spectrometry showed highly comparable profiles for the
reference and platform medium. An overview of the
glycoanalysis is given in Table 1.
As an additional application, the platform medium
was successfully utilized as a basis for a chemically
defined cloning medium in limited dilution experiments.
For different cell lines single cell growth was achieved* Correspondence: Tim.Beckmann@teutocell.de
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and cells were effectively expanded from 96-well plate
format up to shaking flask cultures.
Conclusions
Within this work a chemically defined and animal-com-
ponent free media platform was successfully implemen-
ted, which supports high performance growth and
productivity without supplementation of proteins or
growth hormones. In addition, its streamlined formula-
tion of less than 50 components increases the design
space for the efficient development of custom formula-
tions. The suitability as a platform medium was verified
by the successful cultivation of a wide range of cell lines
including CHO-DG44, CHO-GS and CHO-K1 clones
and the feature of easy adaption from serum containing
and commercially available formulations. For all tested
Figure 1 Comparison of growth performance (A) and product titer (B) using the reference and platform medium. To illustrate the
improvement in relation to the reference medium, the mean of 5 producer- and the corresponding parental cell line were normalized to the
results obtained in the reference medium (C and D). The error bars show the deviation between the different cell lines. The development
progress of the platform medium is represented by one major interstage.
Table 1 Comparison of the glycosylation pattern of a model antibody produced in two different cell lines using the
reference medium and the platform medium.
Structure Relative Amount of Glycan Structure [%]













Man3 - - - 4 ± 2 1 ± 2 -
Man5 7 ± 2 3 ± 2 5 ± 2 12 ± 3 9 ± 2 4 ± 1
G0F-GlcNAc 2 ± 2 2 ± 1 4 ± 2 10 ± 4 5 ± 0 2 ± 2
G0F 46 ± 2 50 ± 5 47 ± 5 47 ± 5 47 ± 2 47 ± 5
G1 6 ± 3 6 ± 2 8 ± 2 3 ± 1 9 ± 1 5 ± 1
G1F 30 ± 3 32 ± 5 29 ± 7 19 ± 2 23 ± 3 35 ± 2
G2F 9 ± 2 7 ± 2 7 ± 2 5 ± 1 6 ± 1 7 ± 2
The relative amounts of detected structures are given in % with the standard deviation of four independent analyses.
Beckmann et al. BMC Proceedings 2013, 7(Suppl 6):P35
http://www.biomedcentral.com/1753-6561/7/S6/P35
Page 2 of 3
cell lines stable high performance cultivations with high
product yields were achieved, with consistent glycosyla-
tion profiles. As a further field of application, the plat-
form medium provides the basis for single cell growth
following limited dilution.
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